Product restructuring daunting task

Influenced by the government’s plan to cut drug prices by an average of 14 percent starting next year, smaller pharmaceutical firms face at times a daunting task of selecting unprofitable products.

However, they are in dilemma how to sort out their products as they are afraid of significant losses in hospital sales.

“Since smaller companies are producing same me-too products, suspending t...